These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38993765)
21. The role of lamin B receptor in the regulation of senescence-associated secretory phenotype (SASP). En A; Takauji Y; Ayusawa D; Fujii M Exp Cell Res; 2020 May; 390(1):111927. PubMed ID: 32126237 [TBL] [Abstract][Full Text] [Related]
22. Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration. Wu Y; Shen S; Shi Y; Tian N; Zhou Y; Zhang X Front Bioeng Biotechnol; 2022; 10():823945. PubMed ID: 35309994 [TBL] [Abstract][Full Text] [Related]
23. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging. Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726 [TBL] [Abstract][Full Text] [Related]
24. Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266 [TBL] [Abstract][Full Text] [Related]
26. Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence-associated secretory phenotype. Wallis R; Josipovic N; Mizen H; Robles-Tenorio A; Tyler EJ; Papantonis A; Bishop CL J Extracell Vesicles; 2021 Feb; 10(4):e12041. PubMed ID: 33659050 [TBL] [Abstract][Full Text] [Related]
27. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP). Malaquin N; Rodier F Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239 [TBL] [Abstract][Full Text] [Related]
28. Strategies for Targeting Senescent Cells in Human Disease. Gasek NS; Kuchel GA; Kirkland JL; Xu M Nat Aging; 2021 Oct; 1(10):870-879. PubMed ID: 34841261 [TBL] [Abstract][Full Text] [Related]
29. Transplanted senescent renal scattered tubular-like cells induce injury in the mouse kidney. Kim SR; Jiang K; Ferguson CM; Tang H; Chen X; Zhu X; Hickson LJ; Tchkonia T; Kirkland JL; Lerman LO Am J Physiol Renal Physiol; 2020 May; 318(5):F1167-F1176. PubMed ID: 32223312 [TBL] [Abstract][Full Text] [Related]
30. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy. Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199 [TBL] [Abstract][Full Text] [Related]
31. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications. Chandrakar L; Ambatwar R; Khatik GL Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999 [TBL] [Abstract][Full Text] [Related]
32. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway. Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532 [TBL] [Abstract][Full Text] [Related]
33. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies. D'Ambrosio M; Gil J Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603 [TBL] [Abstract][Full Text] [Related]
34. The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases. Cuollo L; Antonangeli F; Santoni A; Soriani A Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33371508 [TBL] [Abstract][Full Text] [Related]
35. Quantitative Proteomic Analysis of the Senescence-Associated Secretory Phenotype by Data-Independent Acquisition. Neri F; Basisty N; Desprez PY; Campisi J; Schilling B Curr Protoc; 2021 Feb; 1(2):e32. PubMed ID: 33524224 [TBL] [Abstract][Full Text] [Related]
36. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs. Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842 [TBL] [Abstract][Full Text] [Related]
37. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss. Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947 [TBL] [Abstract][Full Text] [Related]
38. Flavonoids in Skin Senescence Prevention and Treatment. Domaszewska-Szostek A; Puzianowska-Kuźnicka M; Kuryłowicz A Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201952 [TBL] [Abstract][Full Text] [Related]
39. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss. Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351 [TBL] [Abstract][Full Text] [Related]
40. Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes. Liang Y; Liang N; Ma Y; Tang S; Ye S; Xiao F Ecotoxicol Environ Saf; 2021 Aug; 219():112343. PubMed ID: 34020271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]